Sergey Kulemzin
Sergey Kulemzin
Researcher, Institute of Molecular and Cellular Biology SB RAS
Подтвержден адрес электронной почты в домене mcb.nsc.ru
НазваниеПроцитированоГод
Evasion of the innate immune response: the Old World alphavirus nsP2 protein induces rapid degradation of Rpb1, a catalytic subunit of RNA polymerase II
I Akhrymuk, SV Kulemzin, EI Frolova
Journal of virology 86 (13), 7180-7191, 2012
1282012
FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA
T Santiago, SV Kulemzin, ES Reshetnikova, NA Chikaev, OY Volkova, ...
International immunology 23 (1), 43-53, 2010
282010
FCRL6 receptor: Expression and associated proteins
SV Kulemzin, AY Zamoshnikova, MY Yurchenko, NY Vitak, AM Najakshin, ...
Immunology letters 134 (2), 174-182, 2011
92011
CAR T-cell therapy: Balance of efficacy and safety
SV Kulemzin, VV Kuznetsova, M Mamonkin, AV Taranin, AA Gorchakov
Molecular Biology 51 (2), 237-250, 2017
62017
VEGFR2-specific FnCAR effectively redirects the cytotoxic activity of T cells and YT NK cells
SV Kulemzin, AA Gorchakov, AN Chikaev, VV Kuznetsova, OY Volkova, ...
Oncotarget 9 (10), 9021, 2018
42018
Modular lentiviral vector system for chimeric antigen receptor design optimization
SV Kulemzin, NA Chikaev, OY Volkova, VV Kuznetsova, AV Taranin, ...
Russian Journal of Bioorganic Chemistry 43 (2), 107-114, 2017
32017
Engineering Chimeric Antigen Receptors
SV Kulemzin, VV Kuznetsova, M Mamonkin, AV Taranin
Acta Naturae (англоязычная версия) 9 (1 (32)), 2017
32017
Characterization of human FCRLA isoforms
S Kulemzin, N Chikaev, O Volkova, E Reshetnikova, A Taranin, ...
Immunology letters 152 (2), 153-158, 2013
32013
Development and Characterization of Domain-Specific Monoclonal Antibodies Produced Against Human SLAMF9
O Volkova, S Guselnikov, L Mechetina, N Chikaev, K Baranov, ...
Monoclonal antibodies in immunodiagnosis and immunotherapy 33 (4), 209-214, 2014
22014
Design and analysis of stably integrated reporters for inducible transgene expression in human T cells and CAR NK-cell lines
SV Kulemzin, DA Matvienko, AH Sabirov, AM Sokratyan, DS Chernikova, ...
BMC medical genomics 12 (2), 44, 2019
12019
FCRLA is an intracellular FcR-related protein that binds IgM, IgG and IgA isotypes in B cells (45.11)
P Burrows, T Santiago, S Kulemzin, E Reshetnikova, N Chikaev, ...
The Journal of Immunology 186 (1 Supplement), 45.11-45.11, 2011
12011
Anti-Idiotypic Monoclonal Antibodies Targeting the Germline Variant of a Broadly Neutralizing HIV-Specific Antibody VRC01
AA Gorchakov, OY Volkova, KO Baranov, DS Chernikova, LV Mechetina, ...
MOLECULAR THERAPY 27 (4), 143-144, 2019
2019
36P CAR-modified natural killer cell line expressing CD47/SIRPa blockers as a combined approach for solid cancer therapy
A Chikaev, A Gorchakov, S Kulemzin, T Belovezhets, D Matvienko, ...
Annals of Oncology 29 (suppl_10), mdy485. 005, 2018
2018
ECAR-NK Cell Platform: Enhancing the CAR-Mediated NK Cell Cytotoxicity via Blockade of the CD47/SIRPa Axis
A Gorchakov, AN Chikaev, SV Kulemzin, OY Volkova, DS Chernikova, ...
MOLECULAR THERAPY 26 (5), 199-199, 2018
2018
Design and Functional Analysis of Fn3-Based Bi-Specific Cars
AA Gorchakov, YG Sizentsova, TN Belovezhets, SV Kulemzin, ...
MOLECULAR THERAPY 26 (5), 60-60, 2018
2018
Diversity of immunoglobulin light chain genes in non-teleost ray-finned fish uncovers IgL subdivision into five ancient isotypes
SV Guselnikov, KO Baranov, AM Najakshin, LV Mechetina, NA Chikaev, ...
Frontiers in Immunology 9, 2018
2018
69P NK-cell based delivery of anticancer therapeutics
O Koval, O Volkova, S Kulemzin, A Gorchakov, A Tkachenko, ...
Annals of Oncology 28 (suppl_11), mdx711. 050, 2017
2017
FnCARs: A Platform Expanding the Repertoire of Proteins Targetable with Chimeric Antigen Receptors
A Gorchakov, S Kulemzin, V Kuznetsova, O Volkova, A Taranin
MOLECULAR THERAPY 25 (5), 272-272, 2017
2017
identification Of The Human Slamf9-receptor Complex: p145
A Sokratian, K Baranov, S Guselnikov, N Chikaev, O Volkova, ...
Tissue Antigens 85 (5), 381-382, 2015
2015
Analysis of in vitro activity of PSCA-spe-cific CARs in the context of human NK cell line YT
DA Matvienko, SV Kulemzin, AS Smagina, TN Belovezhets, AN Chikaev, ...
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20